Affiliation:
1. Department of Human Genetics University of Michigan Medical School Ann Arbor Michigan USA
2. Department of Medical Genetics Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow Uttar Pradesh India
3. Department of Pediatric Neurology Indira Gandhi Institute of Child Health Bangalore India
4. Department of Neuropathology National Institute of Mental Health and Neurosciences Bangalore India
Abstract
AbstractCombined oxidative phosphorylation deficiency type 53 (COXPD53) is an autosomal recessive neurodevelopmental disorder (NDD) caused by homozygous variants in the gene C2orf69. Here, we report a novel frameshift variant c.187_191dupGCCGA, p.D64Efs*56 identified in an individual with clinical presentation of COXPD53 with developmental regression and autistic features. The variant c.187_191dupGCCGA, p.D64Efs*56 represents the most N‐terminal part of C2orf69. Notable clinical features of COXPD53of the proband include developmental delay, developmental regression, seizures, microcephaly, and hypertonia. Structural brain defects of cerebral atrophy, cerebellar atrophy, hypomyelination, and thin corpus callosum were also observed. While we observe strong phenotypic overlap among affected individuals with C2orf69 variants, developmental regression and autistic features have not been previously described in individuals with COXPD53. Together, this case expands the genetic and clinical phenotypic spectrum of C2orf69‐associated COXPD53.
Funder
Department of Biotechnology, Ministry of Science and Technology, India
Indian Council of Medical Research
Subject
Genetics (clinical),Genetics